Health

BD to become exclusive global license partner (excluding China) for Bactiguard coated Foley catheters

STOCKHOLM, Dec. 14, 2023 /PRNewswire/ -- Bactiguard Holding AB (publ.) today announces strengthened ties with leading global medical technology company Becton Dickinson & Company (BD), Bactiguard's longest and strongest license collaboration. An interim agreement has been signed granting BD an exc...

2023-12-14 17:53 1637

Vantage Foundation's Wishing Well Initiative Brings Joy To Rumah Hope Children's Home In Malaysia

PETALING JAYA, Malaysia, Dec. 14, 2023 /PRNewswire/ -- This holiday season, Vantage Foundation is lighting up the lives of underprivileged youth at Rumah Hope Children's Home inMalaysia with a heartwarming initiative designed to foster sensitivity and inclusivity during festive holidays. The "...

2023-12-14 17:05 2250

MGI Australia unveils its CEC with DCS Lab products featuring pioneering technology in DNA, Cell, and Spatial-omics Technology

Australia first market outside China to access revolutionary new capability BRISBANE, Australia, Dec. 14, 2023 /PRNewswire/ -- MGI Australia, a subsidiary ofMGI Tech Co. Ltd. (MGI), a global leader i...

2023-12-14 13:13 2258

Pretty Beauty Group Leads the Beauty Tech Trend with the Introduction of LDM Triple 19

HONG KONG, Dec. 14, 2023 /PRNewswire/ -- Pretty Beauty Group once again demonstrates its commitment to leading the market by introducing a revolutionary beauty device - LDM Triple 19. This groundbreaking technology, known as the LDM® Skin Cell Regeneration Device, has been meticulously developed...

2023-12-14 12:27 1642

Antengene Announces Inclusion of XPOVIO® (selinexor) in 2023 China's National Reimbursement Drug List

SHANGHAI and HONG KONG, Dec. 14, 2023 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for cance...

2023-12-14 09:55 2028

The Inaugural Fosun Health Conference on Guangdong-Hong Kong-Macao Healthcare Development Integration Held in Hong Kong to Promote "Three Links" Development

HONG KONG, Dec. 14, 2023 /PRNewswire/ -- The Inaugural Fosun Health Conference onGuangdong-Hong Kong-Macao Healthcare Development Integration was successfully held inHong Kong by Fosun Health on December 12, 2023. With the background of integrating medical services ofGuangdong, Hong Kong and Maca...

2023-12-14 09:00 3917

Crown Aesthetics Announces Groundbreaking Study on Skin Microbiome-Optimized BIOJUVE™ Regimen

Study Reveals Remarkable Results in Aesthetic Treatment Recovery DALLAS, Dec. 14, 2023 /PRNewswire/ -- Crown Aesthetics, a Crown Laboratories, Inc. company ("Crown"), announced today that its groundbreaking clinical study, recently accepted for publication in the Journal of Clinical and Aesthetic...

2023-12-14 03:56 1697

GREATER DES MOINES PARTNERSHIP ANNUAL DINNER SPEAKER ANNOUNCED

GREATER DES MOINES, Iowa, Dec. 13, 2023 /PRNewswire/ -- The Greater Des Moines Partnership has announced that its 2024 Annual Dinner will take place on Thursday, Jan. 25, 2024 at the Community Choice Credit Union Convention Center. The Partnership's Annual Dinner is the Greater Des Moines (DSM) bu...

2023-12-13 22:30 1651

COP28: Angel Yeast's Environmentally Friendly Yeast Protein Empowers Sustainability Development

SHANGHAI, Dec. 13, 2023 /PRNewswire/ -- Angel Yeast , (SH600298), the world's leading yeast manufacturer, is responding to the call of action ofCOP28 which is taking place from November 30 to December 12 in Dubai with concrete actions and sustainable solutions.

2023-12-13 22:04 3081

Immunocan Provides Update on Business Operations, Highlighting Launch of New Gene-edited Mice Generating Fully Human Heavy-chain-only Antibodies and Advances in Partner Pipeline

SHANGHAI, Dec. 13, 2023 /PRNewswire/ -- Shanghai Immunocan Biotech Co., Ltd. ("Immunocan") announcesthe launch of its ImmuMab Heavy® mice. These gene-edited mice, developed by modifying the constant region genes of heavy chains in the ImmuMab® mouse, generate fully human heavy-chain-only antibodi...

2023-12-13 22:00 1942

Molecular Loop Biosciences Receives $1.8 Million to Expand Multi-pathogen Genomics Products for Respiratory Infections

WOBURN, Mass., Dec. 13, 2023 /PRNewswire/ -- Molecular Loop Biosciences, Inc., an innovator at the forefront of targeted sequencing technologies, is pleased to announce that it has received a$1.8 million grant from the Bill & Melinda Gates Foundation to further its groundbreaking work in the fiel...

2023-12-13 21:00 1653

Imagion Announces Positive Results from IBI10103 Phase I Study Demonstrating Safety and Clinical Feasibility of Molecular MRI with MagSense® HER2 Imaging Agent

MELBOURNE, Australia and SAN DIEGO, Dec. 13, 2023 /PRNewswire/ -- Imagion Biosystems Limited (ASX: IBX) recently announced positive results following completion of the IBI10103 phase I clinical trial evaluating the safety and clinical feasibility ofMagSense® HER2 Imaging Agent (MSH2IA) as an adju...

2023-12-13 19:00 1895

Transcenta Announces the Publication of Preclinical Results of [177Lu]Lu-TST001 Radionuclide Antibody Conjugate as Potential Novel Treatment Option for Metastatic Gastric Cancer in the European Journal of Nuclear Medicine and Molecular Imaging

PRINCETON, N.J. and SUZHOU, China, Dec. 13, 2023 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces ...

2023-12-13 18:01 2243

Innovent Announces Inclusion in the China National Reimbursement Drug List of TYVYT® 's Seventh Indication and BYVASDA®'s Eighth Indication

ROCKVILLE, Md. and SUZHOU, China, Dec. 13, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology an...

2023-12-13 12:56 3114

Millions of Australian kids at risk as families struggle to cool dangerously hot homes in cost of living crisis

SYDNEY, Dec. 13, 2023 /PRNewswire/ -- As another record-setting summer approaches, millions of Australian families will be unable to keep their kids cool in dangerously hot homes, with cost-of-living pressures stretching households to the financial limit, a new report from Parents for Climate

2023-12-13 08:00 1737

Clover Initiates Phase Ⅰ Clinical Trial for RSV Vaccine Candidate

--First Chinese RSV PreF Vaccine Candidate to Enter Clinical Trial Stage-- SHANGHAI, Dec. 13, 2023 /PRNewswire/ -- Clover Biopharmaceuticals, Ltd.  (Clover; HKEX: 02197), a global commercial-stage biotechnology company committed to unleashing the power of innova...

2023-12-13 07:42 1862

The NDA for New Indication of Henlius Anti-PD-1 mAb Serplulimab in Combination with Chemotherapy for the First-line Treatment of non-squamous NSCLC Accepted by the NMPA

SHANGHAI, Dec. 12, 2023 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that the NDA for new indication of HANSIZHUANG, serplulimab, an innovative anti-PD-1 mAb independently developed by the company, in combination with chemotherapy as a first-line treatment for patients with...

2023-12-12 20:30 2206

Dr. Eliza Fok, Chairman of the Hong Kong Breast Cancer Foundation Is Honoured with "Women of Power 2023" by Prestige Hong Kong

HONG KONG, Dec. 12, 2023 /PRNewswire/ -- Hong Kong Breast Cancer Foundation (HKBCF) is proud to announce that Dr. Eliza Fok, Chairman of HKBCF, has been honoured with "Women of Power 2023" by leadingHong Kong magazine Prestige Hong Kong. HKBCF extends its congratulations to Dr. Fok on this achie...

2023-12-12 17:58 1726

Illumina partners with HaploX to build a domestically produced flagship benchtop sequencing system

SHENZHEN, China, Dec. 12, 2023 /PRNewswire/ -- On December 9, Illumina, a global leader in DNA sequencing and array-based technologies, and HaploX, aChina -based high-tech company specializing in oncology liquid biopsy and genetic big data, jointly announced the official launch of the first NextSe...

2023-12-12 17:31 2430

ICP DAS - BMP's Medical-Grade TPU Takes Center Stage at Top Global Medical & Plastic Exhibitions

HSINCHU, Dec. 12, 2023 /PRNewswire/ -- ICP DAS (3577-TW) New Business Unit, ICP DAS – BMP, actively ramps up medical-grade TPU (thermoplastic polyurethane) development and production as well as international marketing. The company's participation at COMPAMED and IPF Japan has been a resounding su...

2023-12-12 16:51 2470
1 ... 93949596979899 ... 580